zum Inhalt

Dr. Egenhard LINK Senior Patent & Licensing Manager Life Sciences, Max-Planck-Innovation GmbH, Munich


 After his final exams in Biology at the Technical University and Ludwig Maximilians University in Munich, Germany, Egenhard Link accomplished his diploma thesis at the Max Planck Institute of Biochemistry in Martinsried. For his Ph.D. and as a Postdoc he conducted research in the Boyer Center for Molecular Medicine, Howard Hughes Medical Institute, at Yale University in New Haven, Connecticut (USA). Among other things, he elucidated the mechanisms of action of tetanus and botulinum neurotoxins.
 After five years in the United States he returned to Germany to become research associate at the Max Planck Institute for Experimental Medicine in Goettingen and to build up the small albeit profitable start-up company Synaptic Systems. In fall 2000, Egenhard Link joined Max Planck Innovation where he holds the position of Senior Patent and Licensing Manager and is responsible for Technology Transfer of Max Planck Institutes in the field of 'Life Sciences'


Association of European Science & Technology Transfer Professionals (ASTP)
Licensing Executive Society (LES)
Pharma Lizenz Club Deutschland (PLCD)


Authored and coauthored over a dozen scientific papers in renowned, peer-reviewed journals such as Journal of Cell Biology, Journal of Biological Chemistry, Genes & Development and Nature